South Korean firm files antimalarial in EU for developing countries
This article was originally published in Scrip
Executive Summary
The South Korean firm Shin Poong Pharmaceutical has filed a regulatory approval application with the European Medicines Agency for a new antimalarial under the agency's little-used article 58 procedure, which provides scientific opinions on new products for use outside the EU.